<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>International Journal of Medical Laboratory</title>
<title_fa>مجله بین المللی علوم آزمایشگاهی</title_fa>
<short_title>IJML</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijml.ssu.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-3706</journal_id_issn>
<journal_id_issn_online>2423-3714</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi></journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1397</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2019</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Prevalence of Occult Hepatitis B Infection among HBsAg Negative Blood Donors in Golestan Province</title>
	<subject_fa>خون شناسی و بانک خون</subject_fa>
	<subject>Hematology &amp; Blood Banking</subject>
	<content_type_fa>پژوهشي</content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background and Aims:&lt;/strong&gt; Occult hepatitis B virus infection (OBI) is known as an important source of hepatitis B virus &lt;em&gt;(HBV)&lt;/em&gt; infection. It is categorized as Hepatitis B surface antigen (HBsAg) not being present and low DNA viral load in serum. In this study, an attempt was made to investigate the outbreak of anti-HBc and OBI among the HBsAg-negative donors in Golestan province.&lt;br&gt;
&lt;strong&gt;Materials and Methods: &lt;/strong&gt;The present cross-sectional experiment was conducted on 3500 voluntary blood donors in Golestan province to examine the presence of human immunodeficiency viruses Ag-Ab, HBsAg, and hepatitis C virus Ab. Then, samples with negative results for the mentioned tests were screened for total HBc antibody (IgM-IgG) through ELISA technique. Afterward, HBV-DNA extraction and R-T PCR assay were conducted for all HBsAg negative samples by using Real ART HBV LC PCR kit on a Light Cycler instrument.&lt;br&gt;
&lt;strong&gt;Results: &lt;/strong&gt;The study participants included 3255 (93%) male and 245 (7%) female. In general, 385 (11%) out of 3500 samples were anti-HBc positive. HBV-DNA results for every sample with either positive or negative anti-HBc were found to be negative.&lt;br&gt;
&lt;strong&gt;Conclusions: &lt;/strong&gt;As the area under study has a high rate of anti-HBc outbreak (11%) without the presence of HBV-DNA, anti-HBc screening can cause blood donor deferrals and limit blood supply; therefore, the HBsAg test with high analytical sensitivity is recommended for HBV screening in this area. Regarding the cost analyses and also the status of HBV endemicity, HBsAg test along with &lt;em&gt;ID&lt;/em&gt;&lt;em&gt;-&lt;/em&gt;&lt;em&gt;NAT&lt;/em&gt; is preferable, if possible, for improving blood safety.&amp;nbsp;&lt;/div&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Blood donors, Hepatitis B , HBsAg 
</keyword>
	<start_page>63</start_page>
	<end_page>70</end_page>
	<web_url>http://ijml.ssu.ac.ir/browse.php?a_code=A-10-298-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Rana</first_name>
	<middle_name></middle_name>
	<last_name>Tabar Asad Laleh</last_name>
	<suffix></suffix>
	<first_name_fa>رعنا</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>تبار اسد</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>z.sharifi@ibto.ir</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Zohreh</first_name>
	<middle_name></middle_name>
	<last_name>Sharifi</last_name>
	<suffix></suffix>
	<first_name_fa>زهره</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>شریفی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>z.sharifi@ibto.ir</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ali Akbar</first_name>
	<middle_name></middle_name>
	<last_name>Pourfathollah</last_name>
	<suffix></suffix>
	<first_name_fa>علی اکبر</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>پورفتح الله</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>z.sharifi@ibto.ir</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Shahram</first_name>
	<middle_name></middle_name>
	<last_name>Samei</last_name>
	<suffix></suffix>
	<first_name_fa>شهرام</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>سامعی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>z.sharifi@ibto.ir</email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
